1. Home
  2. CHR vs MGNX Comparison

CHR vs MGNX Comparison

Compare CHR & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheer Holding Inc.

CHR

Cheer Holding Inc.

HOLD

Current Price

$0.80

Market Cap

142.9M

Sector

Technology

ML Signal

HOLD

Logo MacroGenics Inc.

MGNX

MacroGenics Inc.

HOLD

Current Price

$3.07

Market Cap

115.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHR
MGNX
Founded
2016
2000
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
142.9M
115.8M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
CHR
MGNX
Price
$0.80
$3.07
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$3.40
AVG Volume (30 Days)
58.7K
1.5M
Earning Date
03-23-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$149,500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$16.14
P/E Ratio
$0.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.03
$0.99
52 Week High
$2.09
$3.50

Technical Indicators

Market Signals
Indicator
CHR
MGNX
Relative Strength Index (RSI) 28.94 60.38
Support Level $0.07 $1.46
Resistance Level $0.84 $3.26
Average True Range (ATR) 0.08 0.22
MACD -0.00 -0.04
Stochastic Oscillator 20.87 62.73

Price Performance

Historical Comparison
CHR
MGNX

About CHR Cheer Holding Inc.

Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.

About MGNX MacroGenics Inc.

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. The company has three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload.

Share on Social Networks: